Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00669682 · ClinicalTrials.gov registry record
T-wave Alternans and Intrathoracic Impedance Measurements
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 9
- Enrollment target
NCT00669682: Completed study, sponsored by Columbia University.
NCT00669682 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00669682 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
T-wave alternans is a test that is currently being used to risk stratify patients with structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is unclear, but may share a common abnormality with conditions of cardiac fluid overload such as heart failure, which is altered intracellular calcium handling. Current Medtronic implantable defibrillators have the capability of monitoring cardiac fluid status via transthoracic impedance measurements. The purpose of this study is to determine if a correlation exists between T-wave alternans status and cardiac volume status, as determined by transthoracic impedance measurements. Secondarily, the study seeks to examine the relationship between arrhythmia frequency and T-wave alternans or cardiac volume status.
Primary Outcome
We wanted to examine whether positive Optivol status corresponded to a higher likelihood of a positive T wave study. The T wave alternans result is determined by a proprietary device that measures T wave and reports the result as negative, positive, or indeterminate. The Optivol measurement is obtained through transthoracic impedance values in the implanted device. We investigated the correlation between Optivol status and T wave alternans status.
Interventions
- OTHER Congestive heart failure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-04 |
What the finished NCT00669682 record still lists
NCT00669682 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Congestive heart failure is the first listed.
NCT00669682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00669682 about?
NCT00669682 is a clinical study titled "T-wave Alternans and Intrathoracic Impedance Measurements". T-wave alternans is a test that is currently being used to risk stratify patients with structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is unclear, but may share a common abnormality with conditions of cardiac fluid overload such as heart failure, which is altered...
What is the current status of trial NCT00669682?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2008-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00669682?
The interventions under investigation include: Congestive heart failure (OTHER).
Who is sponsoring clinical trial NCT00669682?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia